You are currently viewing a new version of our website. To view the old version click .

Antibodies, Volume 2, Issue 1

March 2013 - 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (10)

  • Article
  • Open Access
13 Citations
7,869 Views
16 Pages

Selection and Characterization of Single Domain Antibodies Specific for Bacillus anthracis Spore Proteins

  • Scott A. Walper,
  • P. Audrey Brozozog Lee,
  • George P. Anderson and
  • Ellen R. Goldman

15 March 2013

To obtain thermostable immunoreagents specific for the spore form of Bacillus anthracis two llamas were immunized with a combination of six different recombinant proteins. These proteins BclA, gerQ, SODA1, SOD15, BxpB and the protein p5303 have all...

  • Review
  • Open Access
7 Citations
17,654 Views
22 Pages

Selective Induction of Cancer Cell Death by Targeted Granzyme B

  • Pranav Oberoi,
  • Robert A. Jabulowsky and
  • Winfried S. Wels

27 February 2013

The potential utility of immunotoxins for cancer therapy has convincingly been demonstrated in clinical studies. Nevertheless, the high immunogenicity of their bacterial toxin domain represents a critical limitation, and has prompted the evaluation o...

  • Article
  • Open Access
6 Citations
10,692 Views
20 Pages

Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine

  • Miho Matsukizono,
  • Mariko Kamegawa,
  • Koichi Tanaka,
  • Shinya Kohra,
  • Koji Arizono,
  • Yuta Hamazoe and
  • Kazuhisa Sugimura

7 February 2013

An immune phage library derived from mice, hyperimmunized with morphine-conjugated BSA, was used to isolate a single-chain Fv (scFv) clone, M86, with binding activity to morphine-conjugated thyroglobulin (morphine-C-Tg) but not to codeine-, cocaine-,...

  • Review
  • Open Access
4 Citations
6,454 Views
11 Pages

28 January 2013

Targeting and killing specific cells discriminately has been the goal of targeted therapy dating back to the era of Paul Ehrlich. The discovery of cancer stem cells has caused a paradigm shift within the cancer field and provided an opportunity to us...

  • Article
  • Open Access
56 Citations
20,317 Views
16 Pages

Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications

  • Katherine Griffiths,
  • Olan Dolezal,
  • Kathy Parisi,
  • Julie Angerosa,
  • Con Dogovski,
  • Miles Barraclough,
  • Abdulmonem Sanalla,
  • Joanne L. Casey,
  • Iveth González and
  • Matthew A. Perugini
  • + 2 authors

25 January 2013

The single variable new antigen receptor domain antibody fragments (VNARs) derived from shark immunoglobulin new antigen receptor antibodies (IgNARs) represent some of the smallest known immunoglobulin-based protein scaffolds. As single domains, they...

  • Review
  • Open Access
21 Citations
13,869 Views
31 Pages

Improving the Therapeutic Potential of Human Granzyme B for Targeted Cancer Therapy

  • Grit Hehmann-Titt,
  • Sonja Schiffer,
  • Nina Berges,
  • Georg Melmer and
  • Stefan Barth

16 January 2013

Conventional cancer treatments lack specificity and often cause severe side effects. Targeted therapeutic approaches are therefore preferred, including the use of immunotoxins (ITs) that comprise cell-binding and cell death-inducing components to all...

  • Article
  • Open Access
1 Citations
7,912 Views
16 Pages

Dissecting the Entry Route of Saporin-based a-CD7 Immunotoxins in Human T-Cell Acute Lymphoblastic Leukaemia Cells

  • Francesco Giansanti,
  • Valeria Giordani,
  • Riccardo Vago,
  • David J. Flavell,
  • Sopsamorn U. Flavell,
  • Maria Serena Fabbrini and
  • Rodolfo Ippoliti

16 January 2013

Elucidating the intracellular fate(s) of targeted toxins is of fundamental importance for their optimal use as anticancer drugs, since the biochemical targets of their enzymatic activity reside in the cell cytoplasm, as in the case of the plant ribos...

  • Article
  • Open Access
12 Citations
8,915 Views
10 Pages

Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages

  • Sonja Schiffer,
  • Dmitrij Hristodorov,
  • Radoslav Mladenov,
  • Eric Aslanian,
  • Michael Huhn,
  • Rainer Fischer,
  • Stefan Barth and
  • Theo Thepen

11 January 2013

Human cytolytic fusion proteins (hCFPs) are comprised of a specific cell-surface-binding moiety and an effector molecule of human origin. In contrast to common immunotoxins, including bacterial or plant toxins, they are considered not to be immunoge...

  • Communication
  • Open Access
7,113 Views
8 Pages

21 December 2012

TATA-box binding protein-associated factor 1 (TAF1), the largest subunit of the transcription factor IID complex, plays an important role in the RNA polymerase II-mediated gene transcription pathway regulating the transcription of a large number of g...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibodies - ISSN 2073-4468